RE7 Labs review
RE7 Labs is the on-chain curation arm of RE7 Capital, running a single small Morpho vault. It posted solid growth over the quarter and keeps utilisation healthy, but the book is fully concentrated in one market and the fee is on the higher side.
The numbers
| Metric | Value | Score | Source |
|---|---|---|---|
| Assets under curatorship29% | $784,927 | 5.5/10 | Morpho 2026-09-22 |
| 90-day growth18% | +32% | 9.0/10 | Morpho 2026-09-22 |
| Concentration24% | 100% | 3.0/10 | Morpho 2026-09-22 |
| Utilisation12% | 88% | 9.0/10 | Morpho 2026-09-22 |
| Fee17% | 20% | 4.0/10 | Morpho 2026-09-22 |
Concentration and utilisation are AUM-weighted across the firm’s listed vaults. Each metric is scored 0–10 on fixed open-data thresholds (see the methodology). Active depositor counts have no reliable open feed, so that metric is left out of the rubric rather than estimated.
- 90-day growth: +32% (9.0/10)
- Utilisation: 88% (9.0/10)
- Concentration: 100% (3.0/10)
- Fee: 20% (4.0/10)
Who it’s for
Depositors comfortable with a smaller, more focused book in exchange for a specific market thesis.
Anyone who wants diversification: almost all of the book sits in one market, so its fate rides on that single position.
Visit RE7 Labs Plain reference — not an affiliate link.